D-Allose [2595-97-3]
Katalog-Nummer NB-64-29097-1mL
Size : 1mLx10mM(inDMSO)
Marke : Neo Biotech
Remove All
D-Allose
(Synonyms: β-D-Allopyranose, D-(+)-ALLOSE) Copy Product InfoSynonyms: β-D-Allopyranose, D-(+)-ALLOSE
Catalog No. T4869 Copy Product Info
Purity: 99.86%
D-Allose (β-D-Allopyranose) is a rare naturally occurring monosaccharide known to exert anti-proliferative effects on cancer cells. The effects of D-Allose on the cellular membranes of hormone-refractory prostate cancer cell line (DU145), hormone-sensitive prostate cancer cell line (LNCaP), and normal prostate epithelial cells (PrEC) were studied at the molecular level by phospholipid profiling using a shotgun lipidomic method.
Cas No. 2595-97-3
For research use only—not for human use. No sales to individuals. Use as intended only.
Select Batch
Purity:99.86%
Appearance:Solid
Color:White
Contact us for more batch information
Product Information
D-Allose AI Summary
D-Allose has a bioactivity characterized by its enzymatic efficiency, specifically with a Kcat/Km ratio of 0.05 /mM/min for the Neisseria meningitidis lgtC enzyme..
Note: Summary generated by AI. Data source: ChEMBL 
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | D-Allose (β-D-Allopyranose) is a rare naturally occurring monosaccharide known to exert anti-proliferative effects on cancer cells. The effects of D-Allose on the cellular membranes of hormone-refractory prostate cancer cell line (DU145), hormone-sensitive prostate cancer cell line (LNCaP), and normal prostate epithelial cells (PrEC) were studied at the molecular level by phospholipid profiling using a shotgun lipidomic method. |
| Synonyms | β-D-Allopyranose, D-(+)-ALLOSE |
| Molecular Weight | 180.16 |
| Formula | C6H12O6 |
| Cas No. | 2595-97-3 |
| Smiles | OC[C@H]1O[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O |
| Relative Density. | 1.2805 g/cm3 (Estimated) |
| Storage | Keep away from direct sunlight,Keep away from moisture, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (277.53 mM), Sonication is recommended.  | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (11.1 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||